This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
dairy calves | 372 |
cryptosporidium parvum | 229 |
milk replacer | 223 |
respiratory disease | 211 |
escherichia coli | 194 |
risk factors | 185 |
calves fed | 169 |
veal calves | 168 |
neonatal calves | 141 |
passive transfer | 139 |
calf diarrhea | 134 |
diarrheic calves | 129 |
clinical signs | 129 |
passive immunity | 112 |
newborn calves | 107 |
young calves | 106 |
bovine respiratory | 96 |
calf mortality | 95 |
present study | 94 |
halofuginone lactate | 93 |
cryptosporidium spp | 93 |
cryptosporidium infection | 92 |
small intestine | 89 |
management practices | 87 |
dairy herds | 86 |
dairy cattle | 85 |
serum igg | 83 |
confinement housing | 80 |
dairy farms | 78 |
bovine coronavirus | 75 |
oocyst shedding | 74 |
fecal samples | 74 |
neonatal calf | 72 |
healthy calves | 72 |
calf health | 71 |
faecal samples | 70 |
united states | 69 |
diarrhoeic calves | 69 |
body weight | 68 |
calf diarrhoea | 68 |
immune system | 67 |
dairy cows | 66 |
factors associated | 62 |
weight gain | 62 |
treatment groups | 61 |
cord uid | 59 |
doc id | 59 |
parvum infection | 59 |
mg kg | 59 |
fed calves | 59 |
animal health | 59 |
control calves | 59 |
calf rearing | 58 |
cryptosporidium species | 58 |
oocyst excretion | 55 |
health status | 55 |
epithelial cells | 55 |
igg concentrations | 55 |
respiratory tract | 54 |
beef calves | 53 |
neonatal diarrhea | 52 |
colostrum feeding | 52 |
infected calves | 52 |
animal welfare | 51 |
per day | 50 |
igg concentration | 49 |
mortality rate | 49 |
calf contact | 48 |
control group | 48 |
antimicrobial drugs | 47 |
cryptosporidium sp | 47 |
colostrum management | 46 |
fluid therapy | 46 |
holstein calves | 46 |
risk assessment | 46 |
dry matter | 44 |
days old | 44 |
weaned calves | 44 |
previous studies | 44 |
mortality rates | 43 |
bovine viral | 43 |
calves may | 43 |
veal calf | 43 |
preweaned calves | 43 |
beef cattle | 42 |
total protein | 42 |
metabolic acidosis | 41 |
first week | 41 |
study period | 41 |
experimental infection | 40 |
current study | 40 |
oxidative stress | 40 |
mg ml | 40 |
treated calves | 40 |
calves housed | 40 |
bovine colostrum | 39 |
heifer calves | 39 |
clinical disease | 39 |
significant differences | 39 |
gnotobiotic calves | 39 |
first days | 38 |
new zealand | 38 |
otitis media | 38 |
mycoplasma bovis | 38 |
colostrum replacer | 38 |
poor welfare | 38 |
parvum oocysts | 37 |
immune response | 37 |
calf starter | 37 |
infectious agents | 37 |
dairy calf | 37 |
significantly higher | 37 |
fecal score | 36 |
calves born | 36 |
fecal dry | 36 |
cryptosporidium baileyi | 36 |
fed colostrum | 35 |
milk replacers | 35 |
molecular characterization | 35 |
serum protein | 35 |
fed milk | 35 |
essential oil | 35 |
waste milk | 35 |
average daily | 34 |
fecal scores | 34 |
old calves | 34 |
group pens | 34 |
cryptosporidium oocysts | 33 |
colostrum intake | 33 |
intestinal tract | 33 |
significantly lower | 33 |
field trial | 33 |
flaxseed oil | 33 |
salmonella spp | 33 |
oregano essential | 32 |
dairy heifers | 32 |
farm animals | 32 |
salmonella typhimurium | 32 |
blood samples | 32 |
white veal | 32 |
individual pens | 32 |
age groups | 32 |
gastrointestinal tract | 31 |
calves received | 31 |
food safety | 31 |
significant difference | 31 |
potential risk | 31 |
farming systems | 31 |
two different | 31 |
increased risk | 31 |
calf welfare | 31 |
adult cattle | 31 |
significantly associated | 31 |
kg bw | 30 |
plasma cortisol | 30 |
bovine rotavirus | 30 |
rotavirus infection | 30 |
goat kids | 30 |
may also | 30 |
veterinary medicine | 30 |
per gram | 29 |
antimicrobial treatment | 29 |
growth performance | 29 |
viral diarrhea | 29 |
milk production | 29 |
ad libitum | 29 |
dairy herd | 29 |
transition milk | 29 |
herd size | 29 |
intestinal epithelial | 29 |
fattening period | 29 |
antimicrobial agents | 28 |
dry period | 28 |
ml kg | 28 |
rumen development | 28 |
one calf | 28 |
calves kept | 28 |
antimicrobial drug | 28 |
first colostrum | 28 |
swedish dairy | 28 |
enteric pathogens | 28 |
previously described | 27 |
sample size | 27 |
nsaid db | 27 |
quality colostrum | 27 |
per cent | 27 |
total number | 27 |
winter dysentery | 27 |
working group | 27 |
hypertonic saline | 27 |
general condition | 27 |
longitudinal study | 27 |
performed using | 27 |
twice daily | 26 |
enteric disease | 26 |
fecal shedding | 26 |
housing calves | 26 |
nasal swabs | 26 |
sick calves | 26 |
fatty acids | 26 |
calves aged | 26 |
neonatal dairy | 26 |
field conditions | 26 |
age group | 26 |
risk factor | 25 |
study ii | 25 |
two calves | 25 |
treatment group | 25 |
mg dl | 25 |
study i | 25 |
four weeks | 25 |
cattle herds | 25 |
alfalfa hay | 25 |
calves reared | 25 |
antibody responses | 25 |
experimentally infected | 25 |
commercially available | 25 |
rearing systems | 25 |
housed calves | 25 |
management factors | 25 |
zoonotic transmission | 25 |
naturally infected | 25 |
veal herds | 25 |
infected animals | 24 |
per calf | 24 |
trt calves | 24 |
diarrhoea virus | 24 |
colostral immunoglobulins | 24 |
older calves | 24 |
oocysts per | 24 |
kg body | 24 |
calves infected | 24 |
neonatal diarrhoea | 24 |
high mortality | 24 |
unrewarded visits | 24 |
infectious diseases | 23 |
scoring system | 23 |
box stall | 23 |
dairy heifer | 23 |
antimicrobial use | 23 |
california dairies | 23 |
public health | 23 |
bull calves | 23 |
calf pens | 23 |
colostrum quality | 23 |
calves treated | 23 |
three calves | 23 |
individual calf | 23 |
rearing unit | 23 |
jersey calves | 23 |
hydrated lime | 23 |
lying behavior | 23 |
diarrheic calf | 23 |
epithelial cell | 23 |
milk feeding | 22 |
production cycle | 22 |
colostral immunoglobulin | 22 |
first weeks | 22 |
calf farming | 22 |
giardia duodenalis | 22 |
veal herd | 22 |
small intestinal | 22 |
three weeks | 22 |
analyzed using | 22 |
haemoglobin levels | 22 |
immune responses | 22 |
total serum | 22 |
severe diarrhea | 22 |
experimental infections | 22 |
rectal temperature | 22 |
enterotoxigenic escherichia | 22 |
oral rehydration | 22 |
positive samples | 22 |
one study | 22 |
colostral igg | 22 |
septicemic calves | 21 |
infrared thermography | 21 |
relative abundance | 21 |
calf herds | 21 |
sodium bicarbonate | 21 |
calf management | 21 |
calf model | 21 |
significantly different | 21 |
beef herds | 21 |
cryptosporidium isolates | 21 |
faecal microbiota | 21 |
body temperature | 21 |
logistic regression | 21 |
respiratory rate | 21 |
state university | 21 |
feeding colostrum | 21 |
villous atrophy | 21 |
economic losses | 21 |
treatment rates | 21 |
several studies | 21 |
group housing | 21 |
diarrhea virus | 21 |
bcov infection | 21 |
weeks old | 20 |
bcov igg | 20 |
systematic review | 20 |
risk calves | 20 |
igg ab | 20 |
fecal microbiota | 20 |
body condition | 20 |
diarrhea problems | 20 |
oral administration | 20 |
ab titers | 20 |
calves effects | 20 |
dairy farm | 20 |
statistically significant | 20 |
large intestine | 20 |
even though | 20 |
two weeks | 20 |
respiratory syncytial | 20 |
viral rna | 20 |
blood haemoglobin | 20 |
room temperature | 20 |
oral electrolyte | 20 |
study design | 20 |
colostrum fed | 19 |
herd level | 19 |
digestive tract | 19 |
scientific veterinary | 19 |
naturally occurring | 19 |
coli isolates | 19 |
eco group | 19 |
calves within | 19 |
odds ratio | 19 |
calves showed | 19 |
daily gain | 19 |
drug use | 19 |
fecal output | 19 |
prepatent period | 19 |
faecal consistency | 19 |
within hours | 19 |
nasal discharge | 19 |
fecal consistency | 19 |
hpn calves | 19 |
commonly used | 19 |
statistical analysis | 19 |
bw gain | 19 |
calves receiving | 19 |
bcov rna | 19 |
human cryptosporidiosis | 19 |
cryptosporidial infection | 19 |
antimicrobial resistance | 18 |
breda virus | 18 |
bovine torovirus | 18 |
preweaned dairy | 18 |
lactase activity | 18 |
matter percentage | 18 |
patent period | 18 |
also reported | 18 |
acute phase | 18 |
different farms | 18 |
scientific opinion | 18 |
specific antibodies | 18 |
box stalls | 18 |
calves effect | 18 |
syncytial virus | 18 |
cr group | 18 |
ng ml | 18 |
intestinal epithelium | 18 |
final model | 18 |
total fecal | 18 |
transmissible gastroenteritis | 17 |
viral diarrhoea | 17 |
bovine cryptosporidiosis | 17 |
campylobacter spp | 17 |
calves prevalence | 17 |
new york | 17 |
kg day | 17 |
induction period | 17 |
health management | 17 |
incidence risk | 17 |
milk allowance | 17 |
newborn calf | 17 |
maternal antibodies | 17 |
growth rates | 17 |
bovine virus | 17 |
iron deficiency | 17 |
farm management | 17 |
immune function | 17 |
direct contact | 17 |
milk intake | 17 |
jugular vein | 17 |
least one | 17 |
preweaning period | 17 |
plasma concentrations | 17 |
oil blend | 17 |
maternal colostrum | 17 |
calving season | 17 |
serum total | 17 |
calf cryptosporidiosis | 17 |
milk fed | 17 |
recent study | 17 |
naturally acquired | 17 |
calves per | 17 |
calves date | 17 |
calf production | 17 |
respiratory pathogens | 17 |
antibiotic resistance | 17 |
individual calves | 17 |
may occur | 17 |
brush border | 17 |
whole milk | 17 |
fecal specimens | 17 |
salmonella newport | 16 |
respiratory infections | 16 |
experimental calves | 16 |
ff treatments | 16 |
antimicrobial therapy | 16 |
rrna gene | 16 |
immunoglobulin absorption | 16 |
mixed infections | 16 |
colostrum within | 16 |
study population | 16 |
experimentally induced | 16 |
recent studies | 16 |
coli strains | 16 |
heart rate | 16 |
nested pcr | 16 |
control pens | 16 |
nasal secretions | 16 |
another study | 16 |
north america | 16 |
control groups | 16 |
maternity pen | 16 |
mammary gland | 16 |
mycobacterium avium | 16 |
closely related | 16 |
two groups | 16 |
randomly assigned | 16 |
antioxidative status | 16 |
associated disease | 16 |
animal care | 16 |
disease control | 16 |
clinical symptoms | 16 |
previously reported | 16 |
factors affecting | 16 |
baileyi infection | 15 |
clinical model | 15 |
data collected | 15 |
negative control | 15 |
cfu ml | 15 |
suckling calves | 15 |
intestinal contents | 15 |
relative abundances | 15 |
study end | 15 |
intestinal absorption | 15 |
dairy cow | 15 |
farmed animals | 15 |
vaccinated cows | 15 |
supplemented transition | 15 |
gut microbiota | 15 |
individual housing | 15 |
among groups | 15 |
pasteurized colostrum | 15 |
eimeria bovis | 15 |
feed efficiency | 15 |
laboratory model | 15 |
sas institute | 15 |
growth rate | 15 |
respiratory cryptosporidiosis | 15 |
first month | 15 |
phase proteins | 15 |
parvum infections | 15 |
foodborne pathogens | 15 |
vaccinated calves | 15 |
may result | 15 |
regression model | 15 |
feedlot cattle | 15 |
calves less | 15 |
feed intake | 15 |
different species | 15 |
cows vaccinated | 14 |
milk substitute | 14 |
older animals | 14 |
among calves | 14 |
authors declare | 14 |
nasal swab | 14 |
broiler chickens | 14 |
fixed effects | 14 |
california dairy | 14 |
calves given | 14 |
milk consumption | 14 |
significantly reduced | 14 |
protein concentration | 14 |
bcv infection | 14 |
per group | 14 |
different types | 14 |
space allowance | 14 |
automatic milk | 14 |
large number | 14 |
dry cows | 14 |
antibiotic treatment | 14 |
wide range | 14 |
data collection | 14 |
fluids given | 14 |
week old | 14 |
hypertonic rehydration | 14 |
pcr products | 14 |
cryptosporidium meleagridis | 14 |
calves presented | 14 |
red deer | 14 |
cryptosporidium infections | 14 |
serum samples | 14 |
first milking | 14 |
upper respiratory | 14 |
times per | 14 |
calf housing | 14 |
mg se | 14 |
rice bran | 14 |
esophageal feeder | 14 |
stall calves | 14 |
samples collected | 14 |
electrolyte solutions | 14 |
therapeutic group | 13 |
electron microscopy | 13 |
individual animal | 13 |
randomly selected | 13 |
water buffalo | 13 |
experimental cryptosporidiosis | 13 |
commonly found | 13 |
treated group | 13 |
ratio fish | 13 |
reared calves | 13 |
three times | 13 |
exposure assessment | 13 |
young dairy | 13 |
early separation | 13 |
amino acids | 13 |
suckling reflex | 13 |
inflammatory drug | 13 |
rotavirus diarrhea | 13 |
higher mortality | 13 |
holstein bull | 13 |
calves bovine | 13 |
pain relief | 13 |
stable enterotoxin | 13 |
oocysts shed | 13 |
first three | 13 |
nervous system | 13 |
cr calves | 13 |
clostridium perfringens | 13 |
multivariable model | 13 |
blood cell | 13 |
milk fever | 13 |
per kg | 13 |
bovis infection | 13 |
trt group | 13 |
abdominal pain | 13 |
oral fluid | 13 |
early detection | 13 |
first wk | 13 |
colostrum may | 13 |
lpn calves | 13 |
norwegian dairy | 13 |
intestinal cryptosporidiosis | 13 |
oregano oil | 13 |
serum immunoglobulin | 13 |
excreting oocysts | 13 |
protective effect | 13 |
daily weight | 13 |
per farm | 13 |
intestinal lumen | 13 |
calves using | 13 |
bicarbonate solution | 13 |
bacterial contamination | 13 |
infectious enteritis | 13 |
friesian calves | 13 |
small ruminants | 13 |
pasteurized waste | 13 |
dairy industry | 13 |
community membership | 13 |
veterinary committee | 13 |
prophylactic use | 13 |
solid feed | 13 |
treatment records | 13 |
environmental contamination | 13 |
control animals | 13 |
bacterial pathogens | 13 |
consecutive days | 13 |
dry feed | 13 |
serum albumin | 13 |
phylogenetic analysis | 13 |
abomasal ulcers | 13 |
electrolyte solution | 13 |
individual hutches | 12 |
beneficial effect | 12 |
salmonella dublin | 12 |
respiratory sounds | 12 |
derived igg | 12 |
model included | 12 |
fed pasteurized | 12 |
positive calves | 12 |
data set | 12 |
group pen | 12 |
may cause | 12 |
suckle reflex | 12 |
housing systems | 12 |
herd studies | 12 |
clinical trial | 12 |
two days | 12 |
intestinal mucosa | 12 |
experimental cryptosporidium | 12 |
exact test | 12 |
disease management | 12 |
herd prevalence | 12 |
lymph nodes | 12 |
first months | 12 |
institute inc | 12 |
statistical analyses | 12 |
shiga toxin | 12 |
invited review | 12 |
viral shedding | 12 |
last years | 12 |
milking cows | 12 |
cryptosporidium muris | 12 |
recovery period | 12 |
air quality | 12 |
repeated measures | 12 |
husbandry systems | 12 |
diagnostic laboratory | 12 |
pl group | 12 |
pasteurized milk | 12 |
fecal sample | 12 |
lying times | 12 |
previous study | 12 |
experimentally challenged | 12 |
white blood | 12 |
blend added | 12 |
calves need | 12 |
high incidence | 12 |
metaphylactic treatment | 12 |
monoclonal antibodies | 12 |
clinical manifestations | 12 |
medicated milk | 12 |
natural infection | 12 |
days post | 12 |
mortality risk | 12 |
pcr assay | 12 |
birth weight | 12 |
liquid feed | 12 |
starter intake | 12 |
colostral leukocytes | 12 |
ff ml | 12 |
adverse effects | 12 |
molecular epidemiology | 12 |
adequate passive | 12 |
antibody titres | 12 |
holstein cows | 12 |
also found | 12 |
described previously | 11 |
results indicate | 11 |
ig absorption | 11 |
immune status | 11 |
experimental studies | 11 |
cell culture | 11 |
nucleotide sequence | 11 |
different calf | 11 |
beef cows | 11 |
posttreatment period | 11 |
individually housed | 11 |
western france | 11 |
linked immunosorbent | 11 |
oocyst counts | 11 |
sampling day | 11 |
high morbidity | 11 |
intensive calf | 11 |
life cycle | 11 |
herd management | 11 |
vaccinated animals | 11 |
calf serum | 11 |
hypertonic bicarbonate | 11 |
drugs used | 11 |
fecal culture | 11 |
control cows | 11 |
affected calves | 11 |
coliform bacteria | 11 |
feeding calves | 11 |
log oocysts | 11 |
colostral immunity | 11 |
calves cryptosporidium | 11 |
villus atrophy | 11 |
welfare aspects | 11 |
rotavirus infections | 11 |
virus diarrhoea | 11 |
fecal oocyst | 11 |
dairy operations | 11 |
monoclonal antibody | 11 |
lamina propria | 11 |
morning feeding | 11 |
dairy science | 11 |
commercial milk | 11 |
disease complex | 11 |
nonpasteurized milk | 11 |
modified live | 11 |
higher prevalence | 11 |
enteric infections | 11 |
health problems | 11 |
management systems | 11 |
personal communication | 11 |
blood cultures | 11 |
parenteral antimicrobial | 11 |
herd health | 11 |
calves raised | 11 |
clinically ill | 11 |
full dose | 11 |
high prevalence | 11 |
geometric mean | 11 |
housed individually | 11 |
farm visit | 11 |
nonsepticemic calves | 11 |
eimeria spp | 11 |
significant association | 11 |
welfare section | 11 |
saleable milk | 11 |
risk analysis | 11 |
udder health | 11 |
calf separation | 11 |
neutralizing antibodies | 11 |
local anesthetic | 11 |
sequence analysis | 11 |
animal species | 11 |
reactive oxygen | 11 |
calf hutches | 11 |
became infected | 11 |
authors thank | 11 |
feeding behavior | 11 |
disease prevention | 11 |
mammary secretions | 11 |
determine whether | 11 |
van weeren | 11 |
individual pen | 11 |
ic samples | 11 |
genotype ii | 11 |
considered significant | 11 |
respiratory diseases | 11 |
bvdv infection | 11 |
calf houses | 11 |
health monitoring | 11 |
diarrhea caused | 11 |
social contact | 11 |
yeast species | 11 |
restricted suckling | 11 |
oral fluids | 11 |
weight loss | 11 |
companion animals | 11 |
overall mortality | 11 |
level risk | 11 |
se head | 11 |
calf pneumonia | 11 |
strains isolated | 11 |
air space | 11 |
passive protection | 11 |
also important | 10 |
oxygen species | 10 |
important cause | 10 |
egg yolk | 10 |
associated risk | 10 |
within minutes | 10 |
producing escherichia | 10 |
successfully treated | 10 |
balf samples | 10 |
antibiotic use | 10 |
sodium chloride | 10 |
large amounts | 10 |
three months | 10 |
independent variables | 10 |
cryptosporidium bovis | 10 |
highest prevalence | 10 |
treatment failures | 10 |
gi tract | 10 |
negative effect | 10 |
dietary changes | 10 |
replacer fed | 10 |
linear mixed | 10 |
first moderate | 10 |
serum ig | 10 |
protein levels | 10 |
different farming | 10 |
bovine rva | 10 |
calves tested | 10 |
fatty acid | 10 |
isolation rate | 10 |
immunoglobulin concentrations | 10 |
fermented milk | 10 |
united kingdom | 10 |
therapeutic use | 10 |
fed groups | 10 |
eimeria zuernii | 10 |
giardia spp | 10 |
bedding material | 10 |
feeding systems | 10 |
time points | 10 |
serum concentrations | 10 |
beef cow | 10 |
growth factors | 10 |
initial treatment | 10 |
bred heifers | 10 |
clinical scores | 10 |
cryptosporidium genotypes | 10 |
future research | 10 |
heat stress | 10 |
early age | 10 |
severe diarrhoea | 10 |
bovine neonates | 10 |
cortisol levels | 10 |
supportive care | 10 |
intraruminal administration | 10 |
regression models | 10 |
higher risk | 10 |
zoonotic potential | 10 |
statistical software | 10 |
lactogenic immunity | 10 |
less likely | 10 |
per animal | 10 |
commercial dairy | 10 |
protective immunity | 10 |
conducted using | 10 |
serum biochemical | 10 |
molecular methods | 10 |
milk solids | 10 |
natural cryptosporidiosis | 10 |
clinical illness | 10 |
physical examination | 10 |
table i | 10 |
coli heat | 10 |
head daily | 10 |
cell loss | 10 |
induced diarrhea | 10 |
salt poisoning | 10 |
around weaning | 10 |
five days | 10 |
villus length | 10 |
mucous membranes | 10 |
haemoglobin concentration | 10 |
pregnant cows | 10 |
untreated calves | 10 |
calf performance | 10 |
srb calves | 10 |
mannheimia haemolytica | 10 |
adult cows | 10 |
tissue samples | 10 |
experimental groups | 10 |
colostrum replacement | 10 |
adult dairy | 10 |
mean age | 10 |
avium ssp | 10 |
high risk | 10 |
enteric nervous | 10 |
four calves | 10 |
nasal colonization | 10 |
increased respiratory | 10 |
six calves | 10 |
rearing calves | 10 |
solid feeds | 10 |
poor growth | 10 |
first feeding | 10 |
feeding pasteurized | 10 |
local anaesthesia | 10 |
humoral immunity | 10 |
blood culture | 10 |
sufficient colostrum | 10 |
lower mortality | 10 |
diarrhea syndrome | 10 |
calving pen | 10 |
clinical examination | 10 |
treatment protocol | 10 |
reduced growth | 9 |
agents associated | 9 |
holstein herds | 9 |
dietary groups | 9 |
last four | 9 |
se supplementation | 9 |
ap activity | 9 |
calf farms | 9 |
factors contributing | 9 |
four herds | 9 |
suckling systems | 9 |
odds ratios | 9 |
orally administered | 9 |
med doi | 9 |
bovine serum | 9 |
hemorrhagic shock | 9 |
microscopic lesions | 9 |
significantly increased | 9 |
mixed model | 9 |
chain reaction | 9 |
also observed | 9 |
slatted floors | 9 |
rewarded visits | 9 |
calculated using | 9 |
viral infections | 9 |
days later | 9 |
radial immunodiffusion | 9 |
crypt epithelium | 9 |
significant effect | 9 |
calves shed | 9 |
brd prevalence | 9 |
dutch dairy | 9 |
predictive value | 9 |
calves will | 9 |
protein concentrations | 9 |
like genotype | 9 |
institutional animal | 9 |
management program | 9 |
respiratory disorders | 9 |
three groups | 9 |
showed signs | 9 |
pasteurella multocida | 9 |
electron microscopic | 9 |
calves evaluation | 9 |
cryptosporidial oocysts | 9 |
immunoglobulin concentration | 9 |
effective treatment | 9 |
calves suffering | 9 |
therapeutic mabs | 9 |
antimicrobial susceptibility | 9 |
studies conducted | 9 |
faecal prevalence | 9 |
determined using | 9 |
replacement heifers | 9 |
immunosorbent assay | 9 |
study calves | 9 |
intestinal motility | 9 |
colostrum ingestion | 9 |
farm level | 9 |
severe metabolic | 9 |
farmed deer | 9 |
cryptosporidium positive | 9 |
nucleotide sequences | 9 |
lime disinfected | 9 |
chicken egg | 9 |
calves comparison | 9 |
diarrhea due | 9 |
may increase | 9 |
calves died | 9 |
biochemical parameters | 9 |
measured using | 9 |
production animals | 9 |
serum amyloid | 9 |
several factors | 9 |
se concentrations | 9 |
predictive values | 9 |
cryptosporidium andersoni | 9 |
virus isolation | 9 |
passive immune | 9 |
three experimental | 9 |
given intravenously | 9 |
condition score | 9 |
treated groups | 9 |
one week | 9 |
db calves | 9 |
reference lists | 9 |
lys activity | 9 |
keverling buisman | 9 |
relatively low | 9 |
confidence interval | 9 |
pathogenic species | 9 |
cryptosporidium hominis | 9 |
parvum oocyst | 9 |
intravenous fluid | 9 |
calves shedding | 9 |
calves experimentally | 9 |
plasma volume | 9 |
one hundred | 9 |
human rotavirus | 9 |
natural infections | 9 |
fluid secretion | 9 |
adaptive immune | 9 |
large numbers | 9 |
maternally derived | 9 |
specific antibody | 9 |
nutritive sucking | 9 |
peracetic acid | 9 |
carbon dioxide | 9 |
factors related | 9 |
samples taken | 9 |
adequate transfer | 9 |
use committee | 9 |
enzyme activities | 9 |
positive effect | 9 |
antibody response | 9 |
intracellular calcium | 9 |
calves efficacy | 9 |
growth factor | 9 |
calf scours | 9 |
production systems | 9 |
calves receive | 9 |
clinical efficacy | 9 |
high levels | 9 |
herd owners | 9 |
day old | 9 |
bos taurus | 9 |
steroidal anti | 9 |
calf faeces | 9 |
increased mortality | 9 |
primarily infected | 9 |
gut closure | 9 |
vaccinated herd | 9 |
cohort study | 9 |
housing conditions | 9 |
oral behaviours | 9 |
pathological changes | 9 |
calves spent | 9 |
postweaning weight | 9 |
council directive | 9 |
total solids | 9 |
turbidity test | 9 |
tested positive | 9 |
group received | 9 |
diarrheic feces | 9 |
data obtained | 9 |
enteropathogenic escherichia | 9 |
significantly greater | 8 |
greater risk | 8 |
pink veal | 8 |
approximately days | 8 |
calves left | 8 |
fed nonpasteurized | 8 |
necrosis factor | 8 |
antibody titers | 8 |
higher levels | 8 |
solid food | 8 |
salmonella enterica | 8 |
evaluated using | 8 |
secretory diarrhea | 8 |
found positive | 8 |
rearing facility | 8 |
susceptibility testing | 8 |
virus infection | 8 |
flunixin meglumine | 8 |
species identification | 8 |
giardia infections | 8 |
safety implications | 8 |
maternity pens | 8 |
pig genotype | 8 |
inadequate colostrum | 8 |
absorptive capacity | 8 |
pen design | 8 |
systemic signs | 8 |
control study | 8 |
nonsteroidal anti | 8 |
haemoglobin level | 8 |
coronavirus infection | 8 |
study identified | 8 |
alimentary tract | 8 |
probability cutoff | 8 |
sodium concentrations | 8 |
coronavirus infections | 8 |
calving area | 8 |
times higher | 8 |
pens huts | 8 |
standard deviation | 8 |
mycobacterium bovis | 8 |
calves consumed | 8 |
veal production | 8 |
female calves | 8 |
one herd | 8 |
colostrum supplementation | 8 |
therapeutic efficacy | 8 |
cause diarrhea | 8 |
evidence suggests | 8 |
scientific committee | 8 |
second week | 8 |
tract disease | 8 |
controlled study | 8 |
accession numbers | 8 |
first report | 8 |
rehydration solution | 8 |
calves usually | 8 |
calves exhibited | 8 |
beneficial effects | 8 |
severely dehydrated | 8 |
block design | 8 |
fed either | 8 |
concurrent infections | 8 |
macconkey agar | 8 |
commonly reported | 8 |
igm concentrations | 8 |
cent dehydrated | 8 |
species distribution | 8 |
luminal ph | 8 |
given subcutaneously | 8 |
lactate treatment | 8 |
categorical variables | 8 |
shedding oocysts | 8 |
low level | 8 |
weaned dairy | 8 |
colostrum supplements | 8 |
immunity transfer | 8 |
previous svc | 8 |
first two | 8 |
hydration status | 8 |
buffered saline | 8 |
dummy nipple | 8 |
hygienic measures | 8 |
veterinary diagnostic | 8 |
alkaline phosphatase | 8 |
outcome variables | 8 |
clinically healthy | 8 |
field study | 8 |
published data | 8 |
wood shavings | 8 |
microbial communities | 8 |
diarrhea associated | 8 |
may lead | 8 |
experimental design | 8 |
study showed | 8 |
infectious causes | 8 |
randomized controlled | 8 |
diarrheic dairy | 8 |
born alive | 8 |
social behaviour | 8 |
gene expression | 8 |
infection occurs | 8 |
intestinal cells | 8 |
milk yield | 8 |
vp gene | 8 |
vaccination status | 8 |
colostrum using | 8 |
descriptive statistics | 8 |
ova concentrations | 8 |
intestinal microbiota | 8 |
calves also | 8 |
treatment effect | 8 |
also used | 8 |
housing system | 8 |
five calves | 8 |
previous report | 8 |
disease status | 8 |
mixed procedure | 8 |
organic dairy | 8 |
science doi | 8 |
nitric oxide | 8 |
recent research | 8 |
collected data | 8 |
study also | 8 |
hygiene measures | 8 |
saline solution | 8 |
linoleic acid | 8 |
negatively associated | 8 |
villous epithelium | 8 |
results suggest | 8 |
diarrhea cases | 8 |
bubalus bubalis | 8 |
abnormal oral | 8 |
high amounts | 8 |
maternal immunity | 8 |
intravenous fluids | 8 |
dependent variable | 8 |
dry food | 8 |
environmental conditions | 8 |
administered orally | 8 |
molecular characterisation | 8 |
fixed factors | 8 |
may differ | 8 |
different age | 8 |
granite fines | 8 |
young animals | 8 |
dichotomous variables | 8 |
deprived calves | 8 |
thermophilic campylobacter | 8 |
human pathogenic | 8 |
avian cryptosporidiosis | 8 |
fpt group | 8 |
amino acid | 8 |
plasma glucose | 8 |
calves older | 8 |
clinical score | 8 |
excreted oocysts | 8 |
groups using | 8 |
cfc samples | 8 |
calf died | 8 |
using two | 8 |
invasive stages | 8 |
least squares | 8 |
may require | 8 |
see table | 8 |
domestic animals | 8 |
health outcomes | 8 |
vaccination programs | 8 |
commercial vaccines | 8 |
mean log | 8 |
younger calves | 8 |
common cause | 8 |
new animals | 8 |
calves compared | 8 |
giardia intestinalis | 8 |
shed oocysts | 8 |
calf barns | 8 |
acute undifferentiated | 8 |
polymerase chain | 8 |
commercial calf | 8 |
infection may | 8 |
higher serum | 8 |
infectious bovine | 8 |
rva strains | 8 |
test results | 7 |
time lying | 7 |
small number | 7 |
european union | 7 |
igg abs | 7 |
significant increase | 7 |
bovine parainfluenza | 7 |
danish cattle | 7 |
abomasal emptying | 7 |
important risk | 7 |
potassium dichromate | 7 |
quercetin aglycone | 7 |
calves excreting | 7 |
veterinary students | 7 |
ae mm | 7 |
challenged neonatal | 7 |
six months | 7 |
assessed using | 7 |
antioxidative capacity | 7 |
two herds | 7 |
observational study | 7 |
may affect | 7 |
bovine enteric | 7 |
blood agar | 7 |
fattening units | 7 |
infectious disease | 7 |
normally distributed | 7 |
daily health | 7 |
calf barn | 7 |
farmed rabbits | 7 |
farm personnel | 7 |
table ii | 7 |
trial sites | 7 |
specific igy | 7 |
final multivariable | 7 |
wheat straw | 7 |
host range | 7 |
passive immunization | 7 |
clinical cryptosporidiosis | 7 |
lagoon water | 7 |
local anesthesia | 7 |
artificially reared | 7 |
different biotypes | 7 |
human health | 7 |
western canada | 7 |
reference strain | 7 |
calves developed | 7 |
subtype iiaa | 7 |
group showed | 7 |
cattle industry | 7 |
epidemiological studies | 7 |
large dairy | 7 |
ph level | 7 |
adjuvanted rotavirus | 7 |
feeding frequency | 7 |
untreated control | 7 |
focal infection | 7 |
etec diarrhea | 7 |
similar results | 7 |
ml igg | 7 |
eimeria species | 7 |
first hours | 7 |
selection criteria | 7 |
like agent | 7 |
sectional study | 7 |
associated calf | 7 |
young cattle | 7 |
heart girth | 7 |
gold standard | 7 |
colostrum igg | 7 |
ethics committee | 7 |
urea nitrogen | 7 |
calves included | 7 |
main foodborne | 7 |
acute pain | 7 |
study herds | 7 |
calf received | 7 |
water station | 7 |
common species | 7 |
young stock | 7 |
old animals | 7 |
protozoan parasites | 7 |
veal meat | 7 |
animal husbandry | 7 |
animal houses | 7 |
average number | 7 |
enteric lesions | 7 |
cautery disbudding | 7 |
respiratory acidosis | 7 |
bronchoalveolar fluid | 7 |
group compared | 7 |
left untreated | 7 |
negative impact | 7 |
statistical significance | 7 |
immune transfer | 7 |
research centre | 7 |
either individual | 7 |
major cause | 7 |
blood loss | 7 |
epidemiological study | 7 |
calf treatment | 7 |
sentinel calves | 7 |
standard operating | 7 |
may contribute | 7 |
reactive protein | 7 |
vaccine placebo | 7 |
data analysis | 7 |
mobile phase | 7 |
flow rate | 7 |
replacer per | 7 |
per production | 7 |
generalized estimating | 7 |
parvum subtype | 7 |
higher odds | 7 |
iron supply | 7 |
important factor | 7 |
negative predictive | 7 |
sucking behaviour | 7 |
serum half | 7 |
faecal score | 7 |
lower respiratory | 7 |
innate immune | 7 |
respiratory syncytical | 7 |
czech republic | 7 |
active immunity | 7 |
factors influencing | 7 |
cryptosporidium pig | 7 |
study reported | 7 |
disease may | 7 |
clinical practice | 7 |
study conducted | 7 |
general linear | 7 |
igg absorption | 7 |
oxidant status | 7 |
animal models | 7 |
enrolled calves | 7 |
mineral supplement | 7 |
fa concentrations | 7 |
growth promoters | 7 |
neonatal immune | 7 |
stall housing | 7 |
respiratory health | 7 |
calves excreted | 7 |
stabilized rice | 7 |
inclusion criteria | 7 |
received colostrum | 7 |
enteric coronavirus | 7 |
one farm | 7 |
calves influence | 7 |
infective particles | 7 |
jersey cows | 7 |
important factors | 7 |
mean number | 7 |
hypertonic solutions | 7 |
positive predictive | 7 |
lying area | 7 |
drinking water | 7 |
bacterial infections | 7 |
productivity study | 7 |
surface area | 7 |
nucleic acid | 7 |
ventilation rates | 7 |
different amounts | 7 |
rice hulls | 7 |
causative agent | 7 |
colostrum collected | 7 |
systemic illness | 7 |
diarrhoea syndrome | 7 |
antibiotic therapy | 7 |
associated diarrhea | 7 |
data loggers | 7 |
holstein friesian | 7 |
dominant species | 7 |
took place | 7 |
two dairy | 7 |
buffalo calves | 7 |
parainfluenza virus | 7 |
small groups | 7 |
relatively high | 7 |
wooden hutches | 7 |
feed calves | 7 |
slatted floor | 7 |
cattle health | 7 |
also considered | 7 |
rotavirus vaccine | 7 |
first treatment | 7 |
particle size | 7 |
colostral derived | 7 |
national animal | 7 |
transmission electron | 7 |
clinical significance | 7 |
antibody products | 7 |
daily administration | 7 |
toxic changes | 7 |
vaccinated dams | 7 |
clinical relevance | 7 |
svc report | 7 |
human intestinal | 7 |
published studies | 7 |
drug therapy | 7 |
disease virus | 7 |
calf level | 7 |
syncytical virus | 7 |
humoral immune | 7 |
struthio camelus | 7 |
conventionally reared | 7 |
meat quality | 7 |
tp calves | 7 |
time rt | 7 |
sodium absorption | 7 |
less time | 7 |
calf feeding | 7 |
rectal temperatures | 7 |
health problem | 7 |
corona virus | 7 |
median amount | 7 |
plasma ph | 7 |
individual crates | 7 |
oocysts excreted | 7 |
standard curve | 7 |
crypt hyperplasia | 7 |
us dairy | 7 |
diarrhea score | 7 |
chronic rd | 7 |
tumor necrosis | 7 |
infectious agent | 7 |
younger animals | 7 |
calves became | 7 |
york state | 7 |
dm basis | 7 |
different management | 7 |
bovine herpesvirus | 7 |
large groups | 7 |
will also | 7 |
lime disinfection | 7 |
ahaw panel | 7 |
economic impact | 7 |
phospholipid fa | 7 |
newborn dairy | 7 |
clostridium difficile | 7 |
straw bedding | 7 |
consistency scores | 7 |
contributing factors | 7 |
recent data | 7 |
colleagues reported | 7 |
mean plasma | 7 |
diarrhea may | 7 |
previous reports | 7 |
genotypes i | 7 |
whole blood | 7 |
mrna expression | 6 |
rva diarrhea | 6 |
organic certified | 6 |
unpublished data | 6 |
respiratory infection | 6 |
salmonella infection | 6 |
given parenterally | 6 |
scientific report | 6 |
individual animals | 6 |
unvaccinated herd | 6 |
possible food | 6 |
vax calves | 6 |
human patients | 6 |
least two | 6 |
replacer diet | 6 |
included articles | 6 |
serum creatinine | 6 |
feeding programs | 6 |
milk feeders | 6 |
values obtained | 6 |
raw colostrum | 6 |
short communication | 6 |
geographic distribution | 6 |
various segments | 6 |
solid foods | 6 |
calves whose | 6 |
colostrum administration | 6 |
uc davis | 6 |
colostral ig | 6 |
fetal membranes | 6 |
secretory response | 6 |
ig concentrations | 6 |
increased morbidity | 6 |
groups within | 6 |
lactic acidosis | 6 |
group nv | 6 |
infected cells | 6 |
shedding bcov | 6 |
study indicated | 6 |
late gestation | 6 |
cryptosporidiosis associated | 6 |
provide evidence | 6 |
inoculated onto | 6 |
community structure | 6 |
independent variable | 6 |
transmission potential | 6 |
lower odds | 6 |
week period | 6 |
log vrc | 6 |
dynamic clinical | 6 |
milk antibody | 6 |
food animal | 6 |
disease incidence | 6 |
serum ova | 6 |
predict septicemia | 6 |
lymphocyte ratio | 6 |
diarrhea onset | 6 |
complete data | 6 |
young calf | 6 |
exposed group | 6 |
gastrointestinal disorders | 6 |
clinical findings | 6 |
gentle contacts | 6 |
preweaned heifer | 6 |
control measures | 6 |
eg calves | 6 |
type i | 6 |
morbidity due | 6 |
effective method | 6 |
digestive disorders | 6 |
model risk | 6 |
persistently infected | 6 |
livestock buildings | 6 |
fluid losses | 6 |
oil administration | 6 |
pathogenic bacteria | 6 |
versus calves | 6 |
incubated overnight | 6 |
two species | 6 |
animal handling | 6 |
heat stable | 6 |
eight calves | 6 |
within days | 6 |
neonatal pigs | 6 |
made available | 6 |
producers treated | 6 |
igg seroconversion | 6 |
unvaccinated controls | 6 |
pasteurised milk | 6 |
detection limit | 6 |
animal diseases | 6 |
longer prepatent | 6 |
experimental study | 6 |
infectious organisms | 6 |
primary pathogen | 6 |
first day | 6 |
mycoplasmal disease | 6 |
kg per | 6 |
identified cryptosporidium | 6 |
physiological changes | 6 |
watery faeces | 6 |
winter months | 6 |
fisher scientific | 6 |
limited number | 6 |
detection rate | 6 |
calf losses | 6 |
viral agents | 6 |
bovine igg | 6 |
study personnel | 6 |
pathogenic coccidia | 6 |
strong ion | 6 |
metal hutches | 6 |
randomly allocated | 6 |
evacuated tubes | 6 |
hypersensitivity reactions | 6 |
agar plates | 6 |
zinc sulfate | 6 |
rehydration therapy | 6 |
fluid intake | 6 |
cr products | 6 |
fecal iga | 6 |
disinfected pens | 6 |
foodborne hazards | 6 |
polyunsaturated fatty | 6 |
replacer feeding | 6 |
high calf | 6 |
calving records | 6 |
management conditions | 6 |
calf respiratory | 6 |
bovine rhinotracheitis | 6 |
diarrhoeal problems | 6 |
provide passive | 6 |
group size | 6 |
survival curves | 6 |
multivariable analysis | 6 |
groove reflex | 6 |
passively acquired | 6 |
time point | 6 |
primary reason | 6 |
secondary bacterial | 6 |
avium subsp | 6 |
brd outbreak | 6 |
holstein heifers | 6 |
bovis bacterin | 6 |
glucose metabolism | 6 |
squares means | 6 |
creatinine concentration | 6 |
without diarrhea | 6 |
newport bacterin | 6 |
milk versus | 6 |
colostral antibodies | 6 |
dually infected | 6 |
higher incidence | 6 |
different ages | 6 |
colony morphology | 6 |
plasma cells | 6 |
true positive | 6 |
immune factors | 6 |
treating calves | 6 |
virus replication | 6 |
per dose | 6 |
interquartile range | 6 |
zoonotic cryptosporidiosis | 6 |
quantitative food | 6 |
management system | 6 |
higher adg | 6 |
intestinal lesions | 6 |
affected animals | 6 |
calf experimental | 6 |
verotoxigenic escherichia | 6 |
tract infections | 6 |
developing countries | 6 |
prophylactic treatment | 6 |
well understood | 6 |
endemically infected | 6 |
method used | 6 |
sum test | 6 |
calf immunity | 6 |
necropsy findings | 6 |
liquid diarrhoea | 6 |
oral behaviors | 6 |
feeding regimen | 6 |
specific serum | 6 |
bovine plasma | 6 |
linear regression | 6 |
bottle feeding | 6 |
three different | 6 |
immunoglobulin transfer | 6 |
producing animals | 6 |
dna extraction | 6 |
intensively reared | 6 |
bethyl laboratories | 6 |
behavioural points | 6 |
every day | 6 |
srb group | 6 |
heifer calf | 6 |
first identified | 6 |
behavioral changes | 6 |
studies reported | 6 |
vet med | 6 |
different rearing | 6 |
cryptosporidium oocyst | 6 |
bovine milk | 6 |
antibody transfer | 6 |
time spent | 6 |
igg serum | 6 |
mucosal surface | 6 |
also identified | 6 |
colostrum samples | 6 |
oxylipid concentrations | 6 |
inflammatory cytokines | 6 |
dairy producers | 6 |
mean serum | 6 |
apt group | 6 |
disease severity | 6 |
time interaction | 6 |
well established | 6 |
oocyst numbers | 6 |
rotaviral diarrhea | 6 |
potential pathogens | 6 |
high air | 6 |
southern ontario | 6 |
morbidity rates | 6 |
mouth disease | 6 |
daily opg | 6 |
transfer status | 6 |
replacer nutrition | 6 |
ruminal drinking | 6 |
born calves | 6 |
proximal small | 6 |
affects calves | 6 |
veterinary clinics | 6 |
calf per | 6 |
border enzyme | 6 |
edward island | 6 |
many countries | 6 |
median adg | 6 |
placebo calves | 6 |
supplemented calves | 6 |
dry cow | 6 |
secretory iga | 6 |
calves required | 6 |
study may | 6 |
disease organisms | 6 |
north american | 6 |
sham calves | 6 |
studies using | 6 |
holstein dairy | 6 |
farm animal | 6 |
causing diarrhoea | 6 |
may vary | 6 |
prince edward | 6 |
results indicated | 6 |
animal production | 6 |
pain associated | 6 |
ae days | 6 |
parvum shedding | 6 |
human medicine | 6 |
factors may | 6 |
observation period | 6 |
member states | 6 |
rotavirus strains | 6 |
serum cortisol | 6 |
canada geese | 6 |
previous findings | 6 |
positive animals | 6 |
rotavirus serotypes | 6 |
calving environment | 6 |
housed dairy | 6 |
veterinary services | 6 |
cart model | 6 |
western canadian | 6 |
become infected | 6 |
fa supplementation | 6 |
predisposing factors | 6 |
surface water | 6 |
weaned piglets | 6 |
reasonably well | 6 |
goose genotypes | 6 |
large molecules | 6 |
approximately weeks | 6 |
studies i | 6 |
low serum | 6 |
vaccination protocol | 6 |
milk powder | 6 |
veterinary use | 6 |
authors also | 6 |
automated measures | 6 |
rank sum | 6 |
without diarrhoea | 6 |
neonatal ruminants | 6 |
colostrum antibodies | 6 |
bacterial taxa | 6 |
nutrient requirements | 6 |
infected neonatal | 6 |
preweaned heifers | 6 |
lower incidence | 6 |
successful passive | 6 |
four times | 6 |
igg levels | 6 |
mycoplasma spp | 6 |
german dairy | 6 |
low sensitivity | 6 |
given orally | 6 |
authors concluded | 6 |
pathogens associated | 6 |
developed diarrhoea | 6 |
maternal vaccination | 6 |
subclinical infection | 6 |
mediated immunity | 6 |
mixed models | 6 |
blood plasma | 6 |
atrophic villi | 6 |
relative humidity | 6 |
veterinary vaccines | 6 |
ammonia concentrations | 6 |
weight data | 6 |
clinical examinations | 6 |
abomasal luminal | 6 |
bcov shedding | 6 |
calf house | 6 |
antibacterial treatment | 6 |
faecal shedding | 6 |
various factors | 6 |
parvum subtypes | 6 |
south america | 6 |
hazard characterisation | 6 |
mg per | 6 |
immunologic patterns | 6 |
least days | 6 |
oral vaccination | 6 |
preruminant calves | 6 |
egg antibodies | 6 |
summer months | 6 |
endocrine traits | 6 |
without pain | 6 |
well plate | 6 |
calf infected | 6 |
symptomatic calves | 6 |
artificial rearing | 6 |
clinical coccidiosis | 6 |
several days | 6 |
calves around | 6 |
mean daily | 6 |
southern britain | 6 |
wilcoxon rank | 6 |
infection rates | 6 |
losses associated | 6 |
replacer powder | 6 |
analysis revealed | 6 |
extracellular fluid | 6 |
bovine immunoglobulins | 6 |
higher body | 6 |
diarrhoea caused | 6 |
dichotomous variable | 6 |
food animals | 6 |
high quality | 6 |
low levels | 6 |
several weeks | 6 |
pathological findings | 6 |
multifactorial disease | 6 |
plasma transfusion | 6 |
lacteal secretions | 6 |
atopic dermatitis | 6 |
automatic feeding | 6 |
may influence | 6 |
ctr calves | 6 |
studies found | 6 |
treatment protocols | 6 |
stool sample | 6 |
different methods | 6 |
random effect | 6 |
feeding system | 6 |
serum antibody | 6 |
stocking density | 6 |
per sample | 6 |
enteric viral | 6 |
predictive ability | 6 |
first four | 6 |
long wheat | 6 |
calf ranch | 6 |
calf heifers | 6 |
cryptosporidium prevalence | 6 |
normal feces | 6 |
water content | 6 |
hutches made | 5 |
live weight | 5 |
research facility | 5 |
first six | 5 |
study demonstrated | 5 |
esophageal groove | 5 |
supplement containing | 5 |
internal parasites | 5 |
herd investigation | 5 |
calf growth | 5 |
fed greater | 5 |
calves reported | 5 |
bovine coccidiosis | 5 |
quality control | 5 |
different pathogens | 5 |
health assessment | 5 |
median percent | 5 |
milking colostrum | 5 |
bovis infections | 5 |
gut flora | 5 |
calves younger | 5 |
applied biosystems | 5 |
two treatment | 5 |
longer period | 5 |
maize silage | 5 |
previous exposure | 5 |
significantly affected | 5 |
colostrum supplement | 5 |
base status | 5 |
logit link | 5 |
diseased animals | 5 |
unvaccinated herds | 5 |
housed veal | 5 |
parvum gp | 5 |
peripheral blood | 5 |
among dairy | 5 |
housing type | 5 |
major problem | 5 |
automatic feeder | 5 |
calf diarrhoeal | 5 |
milk protein | 5 |
concentrates consumed | 5 |
fluid administration | 5 |
chicks inoculated | 5 |
mortem examination | 5 |
epithelium may | 5 |
juvenile ruminants | 5 |
urine production | 5 |
like particle | 5 |
mean total | 5 |
nine calves | 5 |
lactating cows | 5 |
calf diseases | 5 |
drug administration | 5 |
following vaccination | 5 |
anim pract | 5 |
dry weight | 5 |
assessment approach | 5 |
faecal suspension | 5 |
bacterial overgrowth | 5 |
kda glycoprotein | 5 |
receiver calves | 5 |
four isolates | 5 |
associated management | 5 |
calves mainly | 5 |
higher milk | 5 |
antibiotic residues | 5 |
may become | 5 |
phosphate buffer | 5 |
virus shedding | 5 |
animal science | 5 |
among treatments | 5 |
oocysts enumerated | 5 |
calf morbidity | 5 |
retained fetal | 5 |
among cows | 5 |
may reduce | 5 |
infection pattern | 5 |
optical density | 5 |
resting behaviour | 5 |
jaccard index | 5 |
interaction terms | 5 |
diarrhea episodes | 5 |
allergenic proteins | 5 |
jejunal mucosa | 5 |
normal distribution | 5 |
losses due | 5 |
veterinary practitioners | 5 |
hutch space | 5 |
decreased appetite | 5 |
rd calves | 5 |
collected directly | 5 |
parvum genotype | 5 |
cattle diarrhea | 5 |
sporadic human | 5 |
day interaction | 5 |
coli isolation | 5 |
repeated measurements | 5 |
time period | 5 |
distal small | 5 |
six weeks | 5 |
diarrhea index | 5 |
health scores | 5 |
first meal | 5 |
clayton index | 5 |
earlier studies | 5 |
described using | 5 |
calves based | 5 |
large animal | 5 |
water bowls | 5 |
igy antibodies | 5 |
showed significantly | 5 |
consultation group | 5 |
virus particles | 5 |
sas version | 5 |
cebu study | 5 |
least three | 5 |
common disease | 5 |
se dams | 5 |
poor suckle | 5 |
cryptosporidiosis among | 5 |
generally accepted | 5 |
shed bcv | 5 |
young dutch | 5 |
much higher | 5 |
increased incidence | 5 |
ill calves | 5 |
field trials | 5 |
incidence rates | 5 |
phase extraction | 5 |
host specificity | 5 |
monitoring system | 5 |
digestive system | 5 |
wide geographic | 5 |
safety risk | 5 |
aerial pollutants | 5 |
raw milk | 5 |
needs index | 5 |
good hygiene | 5 |
calf weaning | 5 |
lower saxony | 5 |
appendix table | 5 |
altered faecal | 5 |
supplementary material | 5 |
related resistance | 5 |
subunit vaccine | 5 |
franklin lakes | 5 |
vet clin | 5 |
bacterial flora | 5 |
correlation coefficient | 5 |
enteric shedding | 5 |
road transport | 5 |
test endpoints | 5 |
severe cases | 5 |
gnotobiotic calf | 5 |
fa ratio | 5 |
also associated | 5 |
southern california | 5 |
bacteria counts | 5 |
calves molecular | 5 |
quercetin feeding | 5 |
cow vaccination | 5 |
every calf | 5 |
true negative | 5 |
table iii | 5 |
preventive measures | 5 |
lacombe research | 5 |
herd sizes | 5 |
low prevalence | 5 |
frozen colostrum | 5 |
high enough | 5 |
rearing conditions | 5 |
coronavirus strains | 5 |
may contain | 5 |
rotavirus excretion | 5 |
moderate disease | 5 |
information criterion | 5 |
intern med | 5 |
beef farms | 5 |
cattle populations | 5 |
chosen based | 5 |
mesenteric lymph | 5 |
sequencing kit | 5 |
label use | 5 |
older studies | 5 |
periparturient rise | 5 |
local antibody | 5 |
categorical variable | 5 |
transmission dynamics | 5 |
serum sodium | 5 |
cell counts | 5 |
energy balance | 5 |
se cows | 5 |
faecal prevalences | 5 |
replacement management | 5 |
colostral antibody | 5 |
colostrum replacers | 5 |
binomial distribution | 5 |
adverse effect | 5 |
normal calves | 5 |
system function | 5 |
body composition | 5 |
fluid loss | 5 |
immune protection | 5 |
group sizes | 5 |
supranutritional se | 5 |
single infections | 5 |
feeding holstein | 5 |
watery feces | 5 |
see chapter | 5 |
extra shade | 5 |
sulfate turbidity | 5 |
coli infection | 5 |
providing passive | 5 |
per liter | 5 |
leading cause | 5 |
shed cryptosporidium | 5 |
intestinal secretion | 5 |
feeding program | 5 |
concrete floor | 5 |
first time | 5 |
collective pens | 5 |
taken directly | 5 |
animals treated | 5 |
diarrhea incidence | 5 |
risk managers | 5 |
pcr assays | 5 |
half dose | 5 |
use practices | 5 |
weeks later | 5 |
derived oxylipids | 5 |
random effects | 5 |
univariable analyses | 5 |
oocyst morphology | 5 |
antimicrobial factors | 5 |
long term | 5 |
european commission | 5 |
intestinal flora | 5 |
states department | 5 |
disease caused | 5 |
increased serum | 5 |
bulk tank | 5 |
additional milk | 5 |
consumed less | 5 |
fecal scoring | 5 |
investigation period | 5 |
chain management | 5 |
final models | 5 |
lying bouts | 5 |
mathematical models | 5 |
water supply | 5 |
house air | 5 |
malabsorptive diarrhea | 5 |
sufficient volume | 5 |
routinely collected | 5 |
cell death | 5 |
biological hazards | 5 |
severe depression | 5 |
infected dairy | 5 |
social contacts | 5 |
high salinity | 5 |
coli biotypes | 5 |
separate pens | 5 |
dead calves | 5 |
specific gravity | 5 |
colostrum produced | 5 |
using generalized | 5 |
coli isolated | 5 |
achieve adequate | 5 |
treated colostrum | 5 |
technical assistance | 5 |
isolates obtained | 5 |
weaning period | 5 |
antibiotic treated | 5 |
mean values | 5 |
rehydration solutions | 5 |
sample collection | 5 |
bacterial counts | 5 |
hepatic mrna | 5 |
clin north | 5 |
acute gastroenteritis | 5 |
controlled field | 5 |
preweaning health | 5 |
assessment tool | 5 |
susceptible calves | 5 |
enteric infection | 5 |
replacers may | 5 |
may show | 5 |
less milk | 5 |
veterinary surgeon | 5 |
mrna abundances | 5 |
collected every | 5 |
dam within | 5 |
agarose gel | 5 |
biotype iii | 5 |
control programmes | 5 |
two farms | 5 |
neutralizing antibody | 5 |
dual enteric | 5 |
male calves | 5 |
also increased | 5 |
daily dose | 5 |
climatic conditions | 5 |
hyperimmune bovine | 5 |
feeding milk | 5 |
one third | 5 |
enzootic bronchopneumonia | 5 |
northeastern spain | 5 |
cell membrane | 5 |
adequate amount | 5 |
virus isolated | 5 |
effect size | 5 |
calves allowed | 5 |
old chicks | 5 |
successful colostrum | 5 |
experimental data | 5 |
oocyst output | 5 |
core temperature | 5 |
larger groups | 5 |
porcine rotavirus | 5 |
results obtained | 5 |
low numbers | 5 |
first described | 5 |
clinical samples | 5 |
calves among | 5 |
rotavirus shedding | 5 |
remained constant | 5 |
trial evaluating | 5 |
acute bvdv | 5 |
complete block | 5 |
health records | 5 |
brazilian cattle | 5 |
remaining calves | 5 |
online version | 5 |
inactivated oil | 5 |
study team | 5 |
study found | 5 |
vaccination program | 5 |
health plans | 5 |
per ml | 5 |
free radicals | 5 |
linear fashion | 5 |
good welfare | 5 |
microscopic examination | 5 |
histophilus somni | 5 |
calf population | 5 |
diarrhoeic samples | 5 |
case reports | 5 |
small intestines | 5 |
lipid peroxidation | 5 |
infrared thermal | 5 |
walled oocysts | 5 |
cent glucose | 5 |
giardia sp | 5 |
calves dying | 5 |
variables included | 5 |
relatively small | 5 |
formic acid | 5 |
brix refractometer | 5 |
sick animals | 5 |
measures analysis | 5 |
nipple use | 5 |
diarrhea problem | 5 |
canadian cow | 5 |
spss inc | 5 |
may still | 5 |
calf behavior | 5 |
health conditions | 5 |
disease spread | 5 |
blood concentrations | 5 |
biofortified alfalfa | 5 |
different serotypes | 5 |
pigs prevalence | 5 |
toxin production | 5 |
neonatal period | 5 |
severe dehydration | 5 |
sodium sulfite | 5 |
preliminary results | 5 |
diagnostic testing | 5 |
high milk | 5 |
pathogenic micro | 5 |
deer calves | 5 |
assessment enabling | 5 |
pract doi | 5 |
first calving | 5 |
randomized complete | 5 |
contaminated bedding | 5 |
fresh colostrum | 5 |
enabling quantitative | 5 |
fecal smear | 5 |
animals within | 5 |
drug exposure | 5 |
increased free | 5 |
hazards associated | 5 |
collected via | 5 |
liquid feces | 5 |
parasitol doi | 5 |
blood ph | 5 |
relationships among | 5 |
human disease | 5 |
oral antimicrobial | 5 |
recent findings | 5 |
may help | 5 |
beef herd | 5 |
two months | 5 |
vet intern | 5 |
elisa kit | 5 |
fed low | 5 |
generic principles | 5 |
lactic acid | 5 |
map prevalence | 5 |
fully functional | 5 |
bobwhite quail | 5 |
acquired diarrhea | 5 |
also significantly | 5 |
respiratory coronavirus | 5 |
enzootic pneumonia | 5 |
blood serum | 5 |
clinical respiratory | 5 |
gp subtype | 5 |
tissue damage | 5 |
dna analysis | 5 |
gastrointestinal infections | 5 |
gnotobiotic piglets | 5 |
supplement products | 5 |
undifferentiated diarrhea | 5 |
sugar fermentation | 5 |
calves feeding | 5 |
study dairies | 5 |
nonpasteurized colostrum | 5 |
experimental period | 5 |
mycobacterium paratuberculosis | 5 |
less painful | 5 |
ldh activity | 5 |
scientific panel | 5 |
fat content | 5 |
challenge studies | 5 |
one animal | 5 |
rna gene | 5 |
also included | 5 |
calves inoculated | 5 |
intramammary infection | 5 |
calves disbudded | 5 |
perfringens type | 5 |
infected herds | 5 |
older age | 5 |
oral electrolytes | 5 |
functional capacity | 5 |
milk refusal | 5 |
relatively common | 5 |
free pufa | 5 |
breeding females | 5 |
continuous variables | 5 |
standard error | 5 |
studies demonstrated | 5 |
one day | 5 |
milking herd | 5 |
containing specific | 5 |
subclinical infections | 5 |
saginata cysticercus | 5 |
experimental pens | 5 |
proximal jejunum | 5 |
continued feeding | 5 |
volume consumed | 5 |
alpaca crias | 5 |
milk feeder | 5 |
good management | 5 |
skin tent | 5 |
general health | 5 |
meleagridis infection | 5 |
positive control | 5 |
venous blood | 5 |
total body | 5 |
colostrum supply | 5 |
month old | 5 |
avian genotype | 5 |
ontario holstein | 5 |
left empty | 5 |
linearly increased | 5 |
commercial vaccine | 5 |
ovis aries | 5 |
using sas | 5 |
tag number | 5 |
british columbia | 5 |
fibrinogen concentration | 5 |
cryptosporidiosis amongst | 5 |
important components | 5 |
prevalence data | 5 |
diagnostic tests | 5 |
bovis vaccines | 5 |
cryptosporidium suis | 5 |
gnotobiotic pigs | 5 |
phosphate buffered | 5 |
undifferentiated neonatal | 5 |
rights reserved | 5 |
sampling days | 5 |
within herd | 5 |
higher use | 5 |
farm staff | 5 |
intestinal transit | 5 |
antigenic relationships | 5 |
probably caused | 5 |
universal risk | 5 |
guinea pigs | 5 |
operating procedures | 5 |
animal needs | 5 |
previously published | 5 |
critical control | 5 |
low concentrations | 5 |
pooled colostrum | 5 |
normal cows | 5 |
large intestines | 5 |
link function | 5 |
young ruminants | 5 |
nutritional plane | 5 |
boehringer ingelheim | 5 |
less severe | 5 |
fecal sampling | 5 |
specific immunoglobulins | 5 |
cryptosporidium ubiquitum | 5 |
salinity water | 5 |
depression score | 5 |
reduced risk | 5 |
oxylipid profiles | 5 |
white scours | 5 |
calf farm | 5 |
yolk antibodies | 5 |
environmental samples | 5 |
per se | 5 |
meier survival | 5 |
infection dynamics | 5 |
important role | 5 |
starter grain | 5 |
cattle herd | 5 |
intestinal damage | 5 |
future studies | 5 |
human infections | 5 |
electrolyte therapy | 5 |
animals may | 5 |
analysis identified | 5 |
outcome variable | 5 |
gp gene | 5 |
receive colostrum | 5 |
disease transmission | 5 |
paromomycin sulphate | 5 |
normal calf | 5 |
clinically affected | 5 |
increased linearly | 5 |
highly variable | 5 |
diarrheagenic escherichia | 5 |
drink water | 5 |
decrease mortality | 5 |
pathogens may | 5 |
york holstein | 5 |
rumen capacity | 5 |
molecular analysis | 5 |
estimating equations | 5 |
herd trials | 5 |
zealand dairy | 5 |
growth retardation | 5 |
fresh water | 5 |
milk flow | 5 |
three methods | 5 |
baileyi isolated | 5 |
calf day | 5 |
weaning strategies | 5 |
calf disease | 5 |
second feeding | 5 |
reporting calf | 5 |
oral antibiotics | 5 |
bloody diarrhea | 5 |
south bohemia | 5 |
calves associated | 5 |
confidence intervals | 5 |
virus transmission | 5 |
animals kept | 5 |
iv treatment | 5 |
phase bottle | 5 |
animals infected | 5 |
oocyst enumeration | 5 |
floor space | 5 |
genetic diversity | 5 |
diarrhoeic calf | 5 |
generalized linear | 5 |
colostrum contains | 5 |
efficacy studies | 4 |
domestic ruminants | 4 |
border enzymes | 4 |
severe disease | 4 |
calves sampled | 4 |
overall prevalence | 4 |
sodium concentration | 4 |
bactrian camel | 4 |
events per | 4 |
science vol | 4 |
calf age | 4 |
tank milk | 4 |
swab specimens | 4 |
fed varying | 4 |
mucosal scrapings | 4 |
injectable antimicrobial | 4 |
different stages | 4 |
across time | 4 |
conventional calves | 4 |
inappetent calves | 4 |
cryptosporidiosis cases | 4 |
whose haemoglobin | 4 |
one month | 4 |
new calf | 4 |
additional articles | 4 |
manure soiling | 4 |
coli vaccine | 4 |
endothelial cells | 4 |
effective farm | 4 |
diagnostic methods | 4 |
recent review | 4 |
wooden slats | 4 |
five freedoms | 4 |
swine farms | 4 |
calf death | 4 |
cryptosporidial infections | 4 |
species cryptosporidium | 4 |
lactate dehydrogenase | 4 |
live vaccine | 4 |
atypical strain | 4 |
experimental trial | 4 |
immunoglobulin content | 4 |
calves intestinal | 4 |
colostrum products | 4 |
calves naturally | 4 |
also thank | 4 |
cattle bovine | 4 |
ordered chronologically | 4 |
detrimental effect | 4 |
sequences deposited | 4 |
first detected | 4 |
beneficial bacteria | 4 |
also consistent | 4 |
genus cryptosporidium | 4 |
adjacent pens | 4 |
financial support | 4 |
paulo state | 4 |
significant associations | 4 |
calfhood morbidity | 4 |
electrolyte powder | 4 |
biocide fusion | 4 |
diarrhea outbreak | 4 |
haemoglobin concentrations | 4 |
chemotherapeutic agents | 4 |
disease onset | 4 |
calves originated | 4 |
produced urease | 4 |
michigan due | 4 |
dehydrated calves | 4 |
beef industry | 4 |
acute enteritis | 4 |
intestinal wall | 4 |
particular reference | 4 |
dm lipid | 4 |
agglutination test | 4 |
inflammatory drugs | 4 |
reference range | 4 |
animal treatment | 4 |
calves three | 4 |